Jefferies Upgrades AstraZeneca (AZN) to Buy; 'Risk-reward is significantly more positive'
Tweet Send to a Friend
(Updated - March 16, 2021 7:49 AM EDT)Jefferies analyst Ian Hilliker upgraded AstraZeneca (NASDAQ: AZN) from Hold to Buy with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
